Ignite Creation Date:
2024-05-06 @ 10:15 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03206931
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2021-09-16
First Post:
2017-06-29
Brief Title:
Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2017-06-29
First Submit QC Date:
June 29 2017
Study First Post Date:
2017-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-08
Last Update Post Date:
2021-09-16
Last Update Post Date Type:
ACTUAL